PACRGCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。PACRG遺伝子サイレンサーは、PACRG CRISPR/Cas9ノックアウトプラスミドとPACRGDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のPACRGCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
PACRG CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PACRG CRISPR/Cas9 KOプラスミド (h) | sc-408641 | h | Gene Knockout | GFP | 0 | ||
PACRG HDRプラスミド (h) | sc-408641-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PACRG Double Nickaseプラスミド (h) | sc-408641-NIC | h | Gene Knockout | Puromycin | 0 | ||
PACRG Double Nickaseプラスミド (h2) | sc-408641-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PACRG CRISPR/Cas9 KOプラスミド (m) | sc-427373 | m | Gene Knockout | GFP | 0 | ||
PACRG HDRプラスミド (m) | sc-427373-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PACRG Double Nickaseプラスミド (m) | sc-427373-NIC | m | Gene Knockout | Puromycin | 0 | ||
PACRG Double Nickaseプラスミド (m2) | sc-427373-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PACRGL CRISPR/Cas9 KOプラスミド (h) | sc-414398 | h | Gene Knockout | GFP | 0 | ||
PACRGL HDRプラスミド (h) | sc-414398-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PACRGL Double Nickaseプラスミド (h) | sc-414398-NIC | h | Gene Knockout | Puromycin | 0 | ||
PACRGL Double Nickaseプラスミド (h2) | sc-414398-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PACRGL CRISPR/Cas9 KOプラスミド (m) | sc-426184 | m | Gene Knockout | GFP | 0 | ||
PACRGL HDRプラスミド (m) | sc-426184-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PACRGL Double Nickaseプラスミド (m) | sc-426184-NIC | m | Gene Knockout | Puromycin | 0 | ||
PACRGL Double Nickaseプラスミド (m2) | sc-426184-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PACRG CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PACRG CRISPR Activationプラスミド (h) | sc-408641-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG CRISPR Activationプラスミド (h2) | sc-408641-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG Lentiviral Activation Particles (h) | sc-408641-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG Lentiviral Activation Particles (h2) | sc-408641-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG CRISPR Activationプラスミド (m) | sc-427373-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG CRISPR Activationプラスミド (m2) | sc-427373-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG Lentiviral Activation Particles (m) | sc-427373-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRG Lentiviral Activation Particles (m2) | sc-427373-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL CRISPR Activationプラスミド (h) | sc-414398-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL CRISPR Activationプラスミド (h2) | sc-414398-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL Lentiviral Activation Particles (h) | sc-414398-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL Lentiviral Activation Particles (h2) | sc-414398-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL CRISPR Activationプラスミド (m) | sc-426184-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL CRISPR Activationプラスミド (m2) | sc-426184-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL Lentiviral Activation Particles (m) | sc-426184-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PACRGL Lentiviral Activation Particles (m2) | sc-426184-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |